Original Research
Accepted on 29 Dec 2025
PILRA serves as a diagnostic and prognostic biomarker and modulates the tumor immune microenvironment and immunotherapy response in breast cancer
- 108 views
Original Research
Accepted on 29 Dec 2025
Original Research
Accepted on 29 Dec 2025
Case Report
Accepted on 29 Dec 2025
Original Research
Accepted on 29 Dec 2025
Review
Accepted on 29 Dec 2025
Original Research
Accepted on 29 Dec 2025
Review
Accepted on 29 Dec 2025
Original Research
Accepted on 29 Dec 2025
Systematic Review
Accepted on 29 Dec 2025
Original Research
Accepted on 29 Dec 2025
Original Research
Accepted on 29 Dec 2025
Original Research
Accepted on 29 Dec 2025
Original Research
Accepted on 29 Dec 2025
Original Research
Accepted on 29 Dec 2025
Original Research
Accepted on 29 Dec 2025
Original Research
Accepted on 29 Dec 2025
Review
Accepted on 29 Dec 2025
Original Research
Accepted on 29 Dec 2025
Review
Accepted on 29 Dec 2025
Original Research
Accepted on 29 Dec 2025
Editorial
Accepted on 29 Dec 2025
Review
Accepted on 29 Dec 2025
Case Report
Accepted on 29 Dec 2025
Case Report
Accepted on 29 Dec 2025